U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 48 results

Status:
US Approved Rx (2016)
First approved in 2003

Class (Stereo):
CHEMICAL (ABSOLUTE)



Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of postoperative and chemotherapy-induced nausea and vomiting (PONV and CINV). Palonosetron is a 5-HT3 receptor antagonist with a strong binding affinity ...
Status:
US Approved Rx (2020)
First approved in 2000

Class (Stereo):
CHEMICAL (ACHIRAL)



Alosetron, marketed under the brand name Lotronex, is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. Alosetron is a potent and selective 5-HT3 receptor antagonist. 5-HT3 recept...
Status:
US Approved Rx (2023)
First approved in 1995

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Sevoflurane is a general anesthetic that is FDA approved for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. Sevoflurane induces a reduction in junctional conductance by decrea...
Status:
US Approved Rx (2009)
First approved in 1993

Class (Stereo):
CHEMICAL (ACHIRAL)



Granisetron is a selective inhibitor of type 3 serotonergic (5-HT3) receptors. The drug is structurally and pharmacologically related to ondansetron, another selective inhibitor of 5-HT3 receptors. The serontonin 5-HT3 receptors are located on the ne...
Status:
US Approved Rx (2007)
First approved in 1991

Class (Stereo):
CHEMICAL (RACEMIC)



Ondansetron (ZOFRAN®) is a selective 5-HT3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by radiotherapy, anesthesia, surgery or cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and ...
Status:
US Approved Rx (2008)
First approved in 1979

Class (Stereo):
CHEMICAL (ACHIRAL)



Metoclopramide is a dopamine D2 antagonist that is used as an antiemetic. Metoclopramide inhibits gastric smooth muscle relaxation produced by dopamine, therefore increasing cholinergic response of the gastrointestinal smooth muscle. It accelerates i...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)


Lerisetron is a 5-hydroxytryptamine3 receptor antagonist. It was under development by FAES Farma for the potential treatment of emesis resulting from chemotherapy. Lerisetron specifically binds to 5-HT3 receptors, located peripherally on vagus nerve ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pumosetrag is a novel, orally active and selective 5-HT 3 agonist. It is a partial agonist in rats and guinea-pig and a full agonist in the mouse, suggesting important species differences in 5-HT3 receptor structure. Pumosetrag had been in phase II c...
Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

Phenyl biguanide (phenylbuguanide, PBG) is a 5-hydroxytryptamine receptor 3 agonist used to study the role of serotonin receptors in the central nervous system. It has been found to trigger dopamine release in the nucleus accumbens of rats. Phenylbig...